As of November 2024, Zydus Lifesciences has a market cap of $13.06B. This makes Zydus Lifesciences the world's 1270th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $10.63B | 27.53% |
2023 | $8.34B | 64.11% |
2022 | $5.08B | -13.08% |
2021 | $5.84B | 1.34% |
2020 | $5.77B | 87.48% |
2019 | $3.08B | -27.02% |
2018 | $4.21B | -19.62% |
2017 | $5.24B | 21.55% |
2016 | $4.31B | 8.88% |
2015 | $3.96B | 2.38% |
2014 | $3.87B | 97.47% |
2013 | $1.96B | -10.18% |
2012 | $2.18B | 28.05% |
2011 | $1.70B | -9.44% |
2010 | $1.88B | 79.38% |
2009 | $1.05B | 143.69% |
2008 | $430.40M | -8.46% |
2007 | $470.18M | -10.14% |
2006 | $523.24M | 41.86% |
2005 | $368.85M | -16.47% |
2004 | $441.61M | 52.29% |
2003 | $289.99M | 222.42% |
2002 | $89.94M | - |